Medical Information Only. Consult your healthcare provider before considering clinical trial enrollment.
Immunodeficiencies: early-phase trial registry
3 of 9 indexed Immunodeficiencies trials are currently recruiting, with more weight in Phase 1-2.
Corpus placement: #1,916 of 28,707 conditions by registered trial count.
9 US clinical trials · 3 currently recruiting · #1,916 of 28,707 conditions by registered trial count
Immunodeficiencies: 9 US clinical trials tracked, 3 recruiting.
Immunodeficiencies is the subject of 9 registered US clinical trials on ClinicalTrials.gov, 3 of them currently open to new participants. 0 are in Phase 3-4 (later-stage) and 5 in Phase 1-2 (earlier-stage). The most active sponsor is Children's Hospital of Philadelphia, running 3 of these trials.
Enrollment posture brief
Registry condition immunodeficiencies
OPEN 3 | RECR 33% | LATE 0 | EARLY 5 | RANK #1916 | SPON 3
Volume-matched condition peers
Nearest open-share peer: Adherence, Treatment (33% recruiting · 6 trials)
Immunodeficiencies lists 3 open slots (33% of 9 indexed trials). Peers are matched on registered volume, not therapeutic-area browse lists. How peer matching works →
Key findings
What ClinicalTrials.gov does not surface for Immunodeficiencies on its own pages , computed from the registry mirror as of 2026-08-08. Each line carries its own denominator so it can be quoted as it stands.
-
Immunodeficiencies is recruiting below its size-band peers.
3 of 9 indexed trials (33.3%) are open to enrollment, against a 46.5% average across 27,806 conditions with fewer than 20 trials. The peer set uses the same ClinicalTrials.gov-derived counts as this page.
-
One sponsor concentrates Immunodeficiencies research.
Children's Hospital of Philadelphia accounts for 3 of 9 trials (33.3%). 6 distinct sponsors appear on at least one study for this condition label.
-
Most Immunodeficiencies trials plan to enrol fewer than 100 people.
Median target enrolment is 60 among the 9 trials that report a genuine target (sentinel values excluded). 6 of those (66.7%) plan for fewer than 100 participants.
-
Immunodeficiencies splits between interventional and observational designs.
6 interventional and 3 observational studies make up this index (66.7% interventional). Study type is sponsor-reported on ClinicalTrials.gov.
Open and recent trials
9 total, page 1 of 1
Studies of the Pathogenesis of HIV Infection in Human Peripheral Blood Cells and/or Body Fluids in People Living With and Without HIV
National Institute of Allergy and Infectious Diseases (NIAID)
NCT00001281
Expanded Access Protocol Using CD3+/CD19+ Depleted PBSC
Children's Hospital of Philadelphia
NCT02356653
Second or Greater Allogeneic Hematopoietic Stem Cell Transplant Using Reduced Intensity Conditioning (RIC)
Masonic Cancer Center, University of Minnesota
NCT01666080
Reduced Intensity Conditioning (RIC) Regimen for Patients With Non-malignant Disorders
Children's Hospital of Philadelphia
NCT01050855
Alpha/Beta T and CD19+ Depleted Peripheral Stem Cells for Patients With Primary Immunodeficiencies
Children's Hospital of Philadelphia
NCT02990819
COVID-19 Vaccination and Outcomes in Individuals With and Without Immune Deficiencies and Dysregulations
National Institute of Allergy and Infectious Diseases (NIAID)
NCT04852276
Study of Melphalan Drug Exposure in Pediatric Hematopoietic Stem Cell Transplant Patients
University of California, San Francisco
NCT03609827
Reduced Intensity Conditioning for Umbilical Cord Blood Transplant in Pediatric Patients With Non-Malignant Disorders
Duke University
NCT00744692
CD34+Selection for Partially Matched Family or Matched Unrelated Adult Donor Transplant
New York Medical College
NCT01049854
Phase Distribution
| Phase | Trial count |
|---|---|
| Phase 1 | 2 |
| Phase 2 | 3 |
Top Sponsors
Named interventions
Most-linked intervention names on Immunodeficiencies records (sponsor-reported on ClinicalTrials.gov). Counts are trial links, not unique products.
US sites by state
Facility locations filed on Immunodeficiencies trials. A trial with sites in several states counts in each.
Source: ClinicalTrials.gov, National Library of Medicine. Data is informational only.
Related
What to do with this Immunodeficiencies page
9 registered trials, 3 currently recruiting, is a starting point for a conversation, not a diagnosis or a recommendation.
- 3 Immunodeficiencies trials are currently recruiting, check eligibility criteria before contacting a site. Browse recruiting trials
- Children's Hospital of Philadelphia sponsors the most Immunodeficiencies trials on record, review their full trial history before evaluating a specific study. See Children's Hospital of Philadelphia's trials
- Bring the specific trial ID (NCT number) to your own doctor before enrolling, this page is a directory, not medical guidance. Read the trial-finding guide
Trial and recruiting counts reflect ClinicalTrials.gov registry status as of the data vintage above; individual trial eligibility and enrollment status can change.
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This Immunodeficiencies condition card totals 9 registered trials; most-linked intervention Reduced Intensity (Fanconi); top US site state Pennsylvania. See our editorial standards & corrections policy, the methodology behind these numbers, the data changelog, or report a data error.